4//SEC Filing
Posard Matthew L. 4
Accession 0001808805-25-000063
CIK 0001808805other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:37 PM ET
Size
5.7 KB
Accession
0001808805-25-000063
Insider Transaction Report
Form 4
Posard Matthew L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-23+45,000→ 45,000 totalExercise: $0.70Exp: 2035-06-23→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month).
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001543792
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 4:37 PM ET
- Size
- 5.7 KB